跳至主要内容
临床试验/JPRN-UMIN000037831
JPRN-UMIN000037831尚未招募未知

Effects of immune system on MRE ingreadients(fermentative degradation substances) liquid intake an open-label, randomized controlled trial - Effects of immune system on MRE ingreadients(fermentative degradation substances) liquid intake an open-label, randomized controlled trial

Miura Clinic, Medical Corporation Kanonkai0 个研究点目标入组 40 人开始时间: 2019年9月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 64years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) Subjects with a history of liver disease, kidney disease, gastrointestinal disease, heart disease, or other diseases that may affect the results of this study, or subjects with a history of surgery (2) Subjects with a disease currently being treated (3) Subjects with food and drug allergies (4) Subjects who have a habit of eating and drinking (5) Those who play intense sports and subjects who are on a diet (6) Subjects taking health foods and medicines that are expected to improve immunity and bowel movement (7) Subjects who may overdose food with a bowel movement improving effect during the study period (8) Subjects with anemia (9) Subjects whose life is irregular (10) Subjects who can not quit the intake of health food (including food for FOSHU and Foods with Function Claims') and designated quasi-drugs during the test period (11) Subjects who are taking medication (OTC drugs, including prescription drugs) continuously (12) Subjects who are excessively consuming alcohol or subjects who cannot ban alcohol from the day before the test to the day (13) Pregnant subjects or subjects who plan to become pregnant or breastfeed during the study period (14) Subjects who have participated in other clinical studies within 4 weeks from the start of this study, subjects who are currently participating in or plan to participate in the study (15) Subjects whose stool volume is equivalent to 1 or less quail eggs (16) Other subjects judged by the investigator as inappropriate

研究者

发起方
Miura Clinic, Medical Corporation Kanonkai

相似试验